Cornercap Investment Counsel Inc Edwards Lifesciences Corp Transaction History

Cornercap Investment Counsel Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $1.75 Million - $2.02 Million	-21,446 Reduced 87.3%	3,119 $294,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $1.82 Million - $2.08 Million	24,565 New	24,565 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $549,436 - $655,362	-5,339 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $20,540 - $25,666	-245 Reduced 4.39%	5,339 $553,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $439,349 - $506,301	5,584 New	5,584 $467,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $584,560 - $743,889	-8,154 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $1.53 Million - $2 Million	-22,841 Reduced 73.69%	8,154 $651,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.78 Million - $2.39 Million	30,995 New	30,995 $2.14 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.